Clinical Trials Directory

Trials / Sponsors / InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedFollow up Study of Patients Having Participated in Clinical Trial 64,185-204
Hyperbilirubinemia, Neonatal
—2013-10-17
CompletedStannsoporfin With Light Therapy for Newborn Babies With Jaundice
Jaundice, Neonatal, Hyperbilirubinemia, Neonatal
Phase 22013-10-16
CompletedObservational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
Jaundice, Neonatal Hyperbilirubinemia
—2008-10-20
TerminatedA Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
Hyperbilirubinemia, Neonatal
Phase 22008-08-01
TerminatedLong-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)
Hyperbilirubinemia
—2006-07-01
CompletedSafety and Pharmacology of Stanate
Hyperbilirubinemia
Phase 22005-09-01
CompletedEfficacy and Safety of Stannsoporfin in Neonates
Nutritional and Metabolic Diseases
Phase 32002-05-01
No Longer AvailableCompassionate Use of Stanate (TM) [Stannsoporfin]
Neonatal Jaundice, Hyperbilirubinemia
——